Q32 Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -756.9% | – | – | – | – | – | – | – | |
| – | +185.3% | +88.4% | +390.1% | +40.9% | +7.2% | -96.1% | +34.9% | -2.4% | -19.7% | |
| – | – | – | – | – | – | +64.4% | +15.3% | +207.1% | +19.8% | |
| – | +3,639.2% | -69.6% | -95.6% | +2,388.1% | -462.9% | – | -2.3% | -136.6% | – | |
| – | -1.6% | +1,173.8% | -12.5% | -82.9% | -35.8% | +3.7% | -99.8% | +1,400.0% | -97.3% | |
| – | +3,498.8% | +49.4% | -57.5% | – | -124.8% | -95.1% | -99.8% | – | -64.9% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -99.0% | +2,233.3% | -144.6% | |
| – | +30,358.9% | +31.0% | +4.8% | -66.4% | -1.7% | -42.4% | -98.6% | +23,333.0% | -103.3% | |
| – | – | -133.2% | – | +952.2% | -166.6% | – | -150.3% | – | -162.7% | |
| – | – | -1,593.1% | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.